Open AccessHyperglycemia After Dolutegravir-Based Antiretroviral Therapy
Author(s) -
Workagegnehu Hailu,
Tsebaot Tesfaye,
Abilo Tadesse
Publication year - 2021
Publication title -
international medical case reports journal
Language(s) - Uncategorized
Resource type - Journals
SCImago Journal Rank - 0.198
H-Index - 11
ISSN - 1179-142X
DOI - 10.2147/imcrj.s323233
Subject(s) - dolutegravir , medicine , regimen , metformin , raltegravir , lipodystrophy , diabetes mellitus , glycemic , polyuria , pharmacology , pediatrics , endocrinology , viral load , human immunodeficiency virus (hiv) , antiretroviral therapy , immunology
Antiretroviral therapies prolong life expectancy and improve the quality of life of HIV-infected patients. Despite the documented benefits of antiretroviral drugs, its use is not without side effects. Here, we report cases of new onset diabetes mellitus after taking a dolutegravir (DTG)-based ART regimen.